Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms
Medullary thyroid carcinoma is a rare malignant tumor originating in parafollicular C cells. It accounts for 5 to 8% of all thyroid cancers. MTC develops in either sporadic (75%) or hereditary form (25%). Genetic and molecular studies have demonstrated the involvement of the RET proto-oncogene in he...
Main Authors: | Ana Luiza Maia, Carla V. Ferreira, Mírian Romitti, Lucieli Ceolin, Débora R. Siqueira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/13/1/221/ |
Similar Items
-
Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection
by: Qin Huang, et al.
Published: (2020-05-01) -
RET splice site variants in medullary thyroid carcinoma
by: Daryoush Saeed-Vafa, et al.
Published: (2024-03-01) -
RET mutations in a large indian family with medullary thyroid carcinoma
by: D M Mahesh, et al.
Published: (2014-01-01) -
Association of medullary sponge kidney and hyperparathyroidism with RET G691S/S904S polymorphism: a case report
by: Muhammad Usman Janjua, et al.
Published: (2018-07-01) -
Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity
by: Tariq Alqahtani, et al.
Published: (2021-06-01)